Revvity, Inc. (RVTY) key performance indicators and operating metrics (9 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Operating Profit Margin from Continuing Operations | 23.60 percent | FY2026-Q1 |
| Adjusted Earnings per Share from Continuing Operations (Non-GAAP) | 1.06 USD_per_share | FY2026-Q1 |
| Adjusted Operating Income from Continuing Operations (Non-GAAP) | 168M | FY2026-Q1 |
| Diagnostics Segment Adjusted Operating Profit Margin (Non-GAAP) | 21.80 percent | FY2026-Q1 |
| Life Sciences Segment Adjusted Operating Profit Margin (Non-GAAP) | 28.70 percent | FY2026-Q1 |
| Diagnostics Segment Adjusted Operating Income (Non-GAAP) | 76M | FY2026-Q1 |
| Life Sciences Segment Adjusted Operating Income (Non-GAAP) | 104M | FY2026-Q1 |
| Reported Revenue Growth from Continuing Operations (Year-over-Year) | 6.00 percent | FY2025-Q4 |
| Organic Revenue Growth from Continuing Operations (Year-over-Year) | 4.00 percent | FY2025-Q4 |
Back to RVTY overview · RVTY earnings · RVTY holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.